mTOR independent alteration in ULK1 Ser758 phosphorylation following chronic LRRK2 kinase inhibition
暂无分享,去创建一个
J. Hardy | P. Giunti | A. Mamais | C. Manzoni | P. Lewis | S. Tooze | M. Soutar | R. Bandopadhyay | H. Plun-Favreau | S. Dihanich | R. Abeti | Mark R. Cookson | J. Hardy
[1] M. Cookson,et al. mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1 , 2016, Scientific Reports.
[2] N. Ktistakis,et al. Digesting the Expanding Mechanisms of Autophagy. , 2016, Trends in cell biology.
[3] X. Zhong,et al. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis , 2016, BMC Biochemistry.
[4] S. Costantini,et al. Blue-Print Autophagy: Potential for Cancer Treatment , 2016, Marine drugs.
[5] C. Kraft,et al. Regulation of Autophagy By Signaling Through the Atg1/ULK1 Complex. , 2016, Journal of molecular biology.
[6] Sangeeta Khare,et al. Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .
[7] C. Campochiaro,et al. Guidelines for the use and interpretation of diagnostic methods in adult food allergy , 2015, Clinical and Molecular Allergy.
[8] Xuejun Jiang,et al. Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A , 2015, Nature Communications.
[9] Angeleen Fleming,et al. Compromised autophagy and neurodegenerative diseases , 2015, Nature Reviews Neuroscience.
[10] J. Schapansky,et al. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. , 2014, Human molecular genetics.
[11] F. J. Romero,et al. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling , 2014, Cell Death and Disease.
[12] Chuong B. Do,et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.
[13] Longxuan Li,et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy , 2014, EMBO reports.
[14] Darío,et al. GSK 2578215 A ; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK 2 kinase inhibitor , 2014 .
[15] B. Joseph,et al. The return of the nucleus: transcriptional and epigenetic control of autophagy , 2013, Nature Reviews Molecular Cell Biology.
[16] P. Giunti,et al. Inhibition of LRRK2 kinase activity stimulates macroautophagy , 2013, Biochimica et biophysica acta.
[17] Michael J. Devine,et al. Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation☆ , 2013, Biochemical and biophysical research communications.
[18] A. Tee,et al. The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis. , 2013, Biochemical Society transactions.
[19] A. Harris,et al. Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival. , 2013, The Biochemical journal.
[20] S. Tooze,et al. Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2 , 2013, Autophagy.
[21] N. Gray,et al. GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor. , 2012, Bioorganic & medicinal chemistry letters.
[22] Sheila M. Thomas,et al. AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization , 2012, Autophagy.
[23] M. Memo,et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.
[24] Robert Clarke,et al. Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .
[25] S. Wesselborg,et al. The incredible ULKs , 2012, Cell Communication and Signaling.
[26] G. Churchill,et al. Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP , 2011, Human molecular genetics.
[27] H. Cai,et al. Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway , 2012, Molecular Neurodegeneration.
[28] S. Wesselborg,et al. Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.
[29] N. Gray,et al. Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2 , 2011, Nature chemical biology.
[30] M. Demirci. Comprehensive Clinical Nephrology 3rd Edition , 2011 .
[31] Richard Wade-Martins,et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. , 2009, Human molecular genetics.
[32] C. Chu,et al. Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells , 2008, Journal of neurochemistry.
[33] C. Ross,et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[35] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[36] Kazuya Nagano,et al. Tor-Mediated Induction of Autophagy via an Apg1 Protein Kinase Complex , 2000, The Journal of cell biology.